Success Story: Premium Processing Success: NIW Approved for An Indian Assistant Academic Research Scientist

Posted by wegreened on March 16, 2026 in General Medicine (Public Health, Clinical Research, Infectious Diseases, Vaccines, Virology, Epidemiology, Clinical Psychology, Psychiatry), NIW

On February 27^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Academic Research Scientist in the Field of Virology (Approval Notice).

General Field: Virology

Position at the Time of Case Filing: Assistant Academic Research Scientist

Country of Origin: India

State of Residence at the Time of Filing: Georgia

Approval Notice Date: February 27^th, 2025

Processing Time: 2 months, 8 days (Premium Processing Requested)

Case Summary:

We are pleased to announce the approval of an EB-2 NIW (National Interest Waiver) petition for a distinguished expert in virology holding a Ph.D. in biochemical engineering and biotechnology. At the time of filing, the client was actively engaged in research and development within the biomedical sciences, focusing on advancing tools and assays for the detection and study of emerging viral pathogens.

Research with Substantial Merit and National Importance:
The client’s proposed endeavor is centered on developing diagnostic assays and platforms to study infectious viruses, with the dual aim of enabling rapid containment of emerging diseases and supporting antiviral and vaccine efficacy testing. This line of research carries broad significance for global public health, particularly in strengthening preparedness against viral outbreaks and enhancing disease management strategies.

Well Positioned to Advance the Proposed Endeavor:
With a robust academic and research background, the client has established herself as a recognized contributor in virology. She has authored 25 peer-reviewed journal articles (including 3 first-authored), 4 preprints (1 first-authored), and 1 first-authored book chapter, all of which showcase her expertise in assay development and viral characterization. Her published work has already gained notable traction in the scientific community, with a total of 808 citations on Google Scholar.

In addition to publications, the client’s professional reputation is reflected in her active service as a reviewer. Having conducted at least 28 peer reviews for respected scientific journals, she has been repeatedly trusted to evaluate cutting-edge research in her field. This recognition underscores both her credibility and her authority in virology and related biomedical disciplines.

Supporting Evidence and Recognition:
The petition further demonstrated her national and international impact by documenting her significant role in advancing viral diagnostic research. Evidence of funding, scientific collaborations, and practical applications of her work reinforced the importance of allowing her to continue her research in the United States.

NIW Approval and Outlook:
NAILG successfully demonstrated that the client’s research is both nationally important and aligned with U.S. healthcare and public health interests. By securing this NIW approval, her ability to continue advancing diagnostic assays and viral monitoring methods has been safeguarded. We look forward to her continued contributions to improving global readiness against emerging infectious diseases.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%